Two treatments for Geographic Atrophy: #Izervay (C5 inhibitor, monthly/bi-monthly injections) and #Syfovre (C3 inhibitor, flexible 25-60 day dosing). Both reduce retinal inflammation via eye injections but target different complement proteins.
Comparing Geographic Atrophy treatments: #Izervay and #Syfovre are both injectable treatments for this severe form of AMD. Izervay targets complement C5, while Syfovre targets C3. Both reduce inflammation in the retina via intravitreal injection and aim to slow vision loss.
#Syfovre is the first treatment proven to slow the progression of geographic atrophy (GA), a serious form of dry age-related macular degeneration (AMD). In clinical studies, Syfovre injections reduced the growth of GA lesions by up to 22% with monthly treatment.
